Protokinetix, Inc. 是一家處於研發階段的生物技術公司,致力於抗衰老糖蛋白的醫學科學研究。公司總部位於俄亥俄州戴爾頓。該公司於2002年1月7日上市。公司專注於抗凍糖蛋白(AFGPs)或抗衰老糖蛋白的醫學科學研究。其抗衰老糖肽應用於眼科、皮膚科、器官移植支援和生物製造領域。AAGPs的商業應用包含多種醫療保健解決方案。該公司尚未開發出具有商業可行性的產品,也未產生任何收入。
PKTX stock price ended at $0.01 on 星期四, after rising 0.00%
On the latest trading day Jul 23, 2026, the stock price of PKTX rose by 0.00%, climbing from $0.01 to $0.01. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.01 and a high of $0.01. Alongside this price increase, trading volume also rose by 50.4K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 2.5K shares were traded, amounting to a market value of approximately $3.9M.